P.J. Katsufrakis is president and CEO, NBME, Philadelphia, Pennsylvania; ORCID: https://orcid.org/0000-0001-9077-9190 .
H.J. Chaudhry is president and CEO, Federation of State Medical Boards, Euless, Texas; ORCID: https://orcid.org/0000-0003-3356-1106 .
Acad Med. 2021 Sep 1;96(9):1236-1238. doi: 10.1097/ACM.0000000000004214.
The COVID-19 pandemic interrupted administration of the United States Medical Licensing Examination (USMLE) Step 2 Clinical Skills (CS) exam in March 2020 due to public health concerns. As the scope and magnitude of the pandemic became clearer, the initial plans by the USMLE program's sponsoring organizations (NBME and Federation of State Medical Boards) to resume Step 2 CS in the short-term shifted to long-range plans to relaunch an exam that could harness technology and reduce infection risk. Insights about ongoing changes in undergraduate and graduate medical education and practice environments, coupled with challenges in delivering a transformed examination during a pandemic, led to the January 2021 decision to permanently discontinue Step 2 CS. Despite this, the USMLE program considers assessment of clinical skills to be critically important. The authors believe this decision will facilitate important advances in assessing clinical skills. Factors contributing to the decision included concerns about achieving desired goals within desired time frames; a review of enhancements to clinical skills training and assessment that have occurred since the launch of Step 2 CS in 2004; an opportunity to address safety and health concerns, including those related to examinee stress and wellness during a pandemic; a review of advances in the education, training, practice, and delivery of medicine; and a commitment to pursuing innovative assessments of clinical skills. USMLE program staff continue to seek input from varied stakeholders to shape and prioritize technological and methodological enhancements to guide development of clinical skills assessment. The USMLE program's continued exploration of constructs and methods by which communication skills, clinical reasoning, and physical examination may be better assessed within the remaining components of the exam provides opportunities for examinees, educators, regulators, the public, and other stakeholders to provide input.
由于公共卫生方面的担忧,2020 年 3 月,COVID-19 大流行中断了美国医师执照考试(USMLE)第 2 步临床技能(CS)考试的实施。随着大流行范围和规模变得更加清晰,USMLE 项目的发起组织(NBME 和州医学委员会联合会)最初在短期内恢复第 2 步 CS 的计划转变为重新启动考试的长期计划,该考试可以利用技术并降低感染风险。对本科和研究生医学教育和实践环境中正在发生的变化的深入了解,再加上在大流行期间提供变革性考试的挑战,导致 2021 年 1 月决定永久停止第 2 步 CS。尽管如此,USMLE 项目仍认为评估临床技能至关重要。作者认为,这一决定将促进评估临床技能的重要进展。促成这一决定的因素包括对在期望的时间框架内实现期望目标的担忧;对自 2004 年第 2 步 CS 推出以来临床技能培训和评估的增强进行了审查;有机会解决安全和健康问题,包括大流行期间考生的压力和健康问题;对医学教育、培训、实践和提供的进步进行了审查;以及致力于追求临床技能评估的创新。USMLE 项目工作人员继续从不同利益相关者那里寻求意见,以塑造和优先考虑技术和方法上的增强,以指导临床技能评估的发展。USMLE 项目继续探索在考试的其余部分中更好地评估沟通技能、临床推理和体格检查的结构和方法,为考生、教育工作者、监管机构、公众和其他利益相关者提供了提供意见的机会。